Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 25 studies | 31% ± 15% | |
endothelial cell | 20 studies | 30% ± 16% | |
astrocyte | 18 studies | 43% ± 15% | |
endothelial cell of lymphatic vessel | 17 studies | 33% ± 14% | |
oligodendrocyte precursor cell | 13 studies | 34% ± 13% | |
GABAergic neuron | 8 studies | 34% ± 17% | |
neuron | 8 studies | 56% ± 27% | |
retinal cone cell | 8 studies | 73% ± 19% | |
vein endothelial cell | 7 studies | 32% ± 19% | |
interneuron | 7 studies | 50% ± 21% | |
retinal rod cell | 7 studies | 43% ± 17% | |
glutamatergic neuron | 7 studies | 43% ± 15% | |
smooth muscle cell | 7 studies | 30% ± 9% | |
capillary endothelial cell | 6 studies | 27% ± 11% | |
adventitial cell | 5 studies | 26% ± 9% | |
connective tissue cell | 4 studies | 27% ± 6% | |
myofibroblast cell | 4 studies | 35% ± 10% | |
brush cell | 4 studies | 43% ± 24% | |
progenitor cell | 3 studies | 34% ± 5% | |
ependymal cell | 3 studies | 52% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 25308.55 | 244 / 245 | 95% | 93.60 | 476 / 502 |
ovary | 100% | 22736.87 | 180 / 180 | 89% | 116.86 | 383 / 430 |
lung | 99% | 12038.56 | 572 / 578 | 87% | 95.82 | 1008 / 1155 |
brain | 86% | 9321.79 | 2264 / 2642 | 100% | 457.87 | 703 / 705 |
breast | 97% | 9873.79 | 446 / 459 | 88% | 86.35 | 986 / 1118 |
thymus | 82% | 5991.22 | 535 / 653 | 76% | 90.81 | 458 / 605 |
uterus | 99% | 26310.09 | 169 / 170 | 52% | 62.22 | 238 / 459 |
bladder | 95% | 30937.62 | 20 / 21 | 55% | 52.11 | 279 / 504 |
esophagus | 87% | 32481.18 | 1264 / 1445 | 63% | 66.37 | 115 / 183 |
intestine | 89% | 23599.14 | 863 / 966 | 50% | 36.39 | 261 / 527 |
skin | 78% | 5260.33 | 1402 / 1809 | 50% | 33.36 | 238 / 472 |
stomach | 50% | 8708.94 | 180 / 359 | 59% | 59.48 | 168 / 286 |
blood vessel | 100% | 32824.92 | 1335 / 1335 | 0% | 0 | 0 / 0 |
adipose | 98% | 11803.07 | 1185 / 1204 | 0% | 0 | 0 / 0 |
pancreas | 1% | 53.66 | 4 / 328 | 89% | 107.88 | 159 / 178 |
adrenal gland | 16% | 882.84 | 41 / 258 | 71% | 101.39 | 164 / 230 |
muscle | 86% | 7559.65 | 688 / 803 | 0% | 0 | 0 / 0 |
spleen | 79% | 4204.97 | 190 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 69% | 54.90 | 31 / 45 |
heart | 67% | 6762.23 | 580 / 861 | 0% | 0 | 0 / 0 |
kidney | 12% | 619.85 | 11 / 89 | 39% | 25.57 | 353 / 901 |
lymph node | 0% | 0 | 0 / 0 | 41% | 14.54 | 12 / 29 |
liver | 0% | 24.72 | 1 / 226 | 8% | 4.59 | 31 / 406 |
eye | 0% | 0 | 0 / 0 | 1% | 1.86 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0010976 | Biological process | positive regulation of neuron projection development |
GO_0048678 | Biological process | response to axon injury |
GO_0006208 | Biological process | pyrimidine nucleobase catabolic process |
GO_0051017 | Biological process | actin filament bundle assembly |
GO_0051491 | Biological process | positive regulation of filopodium assembly |
GO_0071345 | Biological process | cellular response to cytokine stimulus |
GO_0010977 | Biological process | negative regulation of neuron projection development |
GO_0048666 | Biological process | neuron development |
GO_0051764 | Biological process | actin crosslink formation |
GO_0030336 | Biological process | negative regulation of cell migration |
GO_0070382 | Cellular component | exocytic vesicle |
GO_0005615 | Cellular component | extracellular space |
GO_0031941 | Cellular component | filamentous actin |
GO_0005829 | Cellular component | cytosol |
GO_0045202 | Cellular component | synapse |
GO_0030426 | Cellular component | growth cone |
GO_0044297 | Cellular component | cell body |
GO_0030027 | Cellular component | lamellipodium |
GO_0031005 | Molecular function | filamin binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0016812 | Molecular function | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides |
GO_0004157 | Molecular function | dihydropyrimidinase activity |
GO_0035374 | Molecular function | chondroitin sulfate binding |
GO_0005515 | Molecular function | protein binding |
GO_0017124 | Molecular function | SH3 domain binding |
Gene name | DPYSL3 |
Protein name | DPYSL3 protein Dihydropyrimidinase-like 3 Dihydropyrimidinase-related protein 3 (DRP-3) (Collapsin response mediator protein 4) (CRMP-4) (Unc-33-like phosphoprotein 1) (ULIP-1) Dihydropyrimidinase like 3 |
Synonyms | DRP3 CRMP4 ULIP1 ULIP |
Description | FUNCTION: Necessary for signaling by class 3 semaphorins and subsequent remodeling of the cytoskeleton. Plays a role in axon guidance, neuronal growth cone collapse and cell migration (By similarity). . FUNCTION: Necessary for signaling by class 3 semaphorins and subsequent remodeling of the cytoskeleton. Plays a role in axon guidance, neuronal growth cone collapse and cell migration. . FUNCTION: Necessary for signaling by class 3 semaphorins and subsequent remodeling of the cytoskeleton. Plays a role in axon guidance, neuronal growth cone collapse and cell migration. . FUNCTION: Necessary for signaling by class 3 semaphorins and subsequent remodeling of the cytoskeleton. Plays a role in axon guidance, neuronal growth cone collapse and cell migration. . |
Accessions | Q6DEN2 ENST00000523458.1 H0YB87 Q14195 ENST00000512722.1 ENST00000398514.7 [Q14195-1] Q8IXW6 H0YBT4 D6RF19 ENST00000343218.10 [Q14195-2] ENST00000520473.1 |